uMedical
Medicines
Substances
Companies
Statistics
Menu
All medicines
Spinraza
Authorised
Human
Orphan medicine
Details
EMA number
EMEA/H/C/004312
ATC code
M09
Authorisation
30 May 2017
Revision
20
EMA page
Therapeutic indication
Spinraza is indicated for the treatment of 5q Spinal Muscular Atrophy.
MeSH:
Muscular Atrophy, Spinal
Group:
Other nervous system drugs
Special characteristics
Accelerated assessment
Active substances
nusinersen sodium
Marketing Authorisation Holder
Biogen Netherlands B.V.
MAH
Timeline
Filter by authority:
EMA
Spinraza authorised
30 May 2017
authorised
regulatory
Spinraza | uMedical